In this study was investigate IAPs in normal human prostate (NP), benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN) and prostatic carcinoma (PC), and their involvement in apoptosis/proliferation via NF-kB (TNF-α, IL-1) stimulation.
Finally, we also analyzed gene expression profiles of prostate stromal cells (PrSC), which were driven to transdifferentiate into premature senescent myofibroblasts by TGFβ1, a process considered a hallmark of the aging human prostate, leading to benign prostatic hyperplasia (Untergasser et al., 2005).
In this study, we systematically evaluated the expression profile and methylation status as well as its clinical relevance of the EphA5 gene in prostate cell lines, benign prostatic hyperplasia, primary human prostate tumors, and paired noncancerous tissues.
46 Intensive investigation of the expression of ERs, especially ERβ and its variants, in human prostate and prostatic diseases, such as hyperplasia and prostate cancer, has shown that ERβ expression declines during hyperplastic changes 40, 47, 48 and ERβ1 is lost during cancer progression, whereas its splice variant, ERβ2, is expressed in advanced prostate cancer.
The properties of human benign prostatic hyperplasia (BPH) and rat prostate were compared after culture in the absence of insulin and testosterone.
For example, the PBCre4×Ptenflox/flox prostate cancer model [17]; (reviewed in [18]) has been shown to mimic human prostate cancer development, including progression from hyperplasia to PIN, to adenocarcinoma and metastasis.
Therefore, compound 12 is a potential multipotent agent that can act as an effective α1-adrenoceptor subtype antagonist for treating benign prostatic hyperplasia and a preventive medication against human prostate cancer.
In this work, the expression of frutalin specific glycoconjugates in human tissues of prostate carcinoma and benign prostate hyperplasia (BPH) was studied by immunohistochemistry.
In 1987, Bedford and van Helden analysed DNA 5′-methylcytosine content in human prostate samples and reported a correlation between global hypomethylation and development of benign prostatic hyperplasia (BPH) and metastatic tumours (Bedford and van Helden 1987).
